(S (NP-SBJ (NP The/DT promoter/NN) (PP of/IN (NP the/DT CD19/NN gene/NN))) (VP is/VBZ (NP-PRD (NP a/DT target/NN) (PP for/IN (NP the/DT B-cell-specific/JJ transcription/NN factor/NN BSAP/NN)))) ./.)
(S (NP-SBJ-26 The/DT CD19/NN protein/NN) (VP-COOD (VP is/VBZ (VP expressed/VBN (NP *-26/-NONE-) (PP on/IN (NP (NP the/DT surface/NN) (PP of/IN (NP all/DT B-lymphoid/JJ cells/NNS)))) (PP with/IN (NP (NP the/DT exception/NN) (PP of/IN (NP (ADJP terminally/RB differentiated/VBN) plasma/NN cells/NNS)))))) and/CC (VP has/VBZ (VP been/VBN (VP implicated/VBN (NP *-26/-NONE-) (PP as/IN (NP a/DT signal-transducing/JJ receptor/NN)) (PP in/IN (NP (NP the/DT control/NN) (PP of/IN (NP-COOD (NP proliferation/NN) and/CC (NP differentiation/NN))))))))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP demonstrate/VBP (NP (NP complete/JJ correlation/NN) (PP between/IN (NP-COOD (NP (NP the/DT expression/NN pattern/NN) (PP of/IN (NP the/DT CD19/NN gene/NN))) and/CC (NP (NP the/DT B-cell-specific/JJ transcription/NN factor/NN BSAP/NN) (PP in/IN (NP (NP a/DT large/JJ panel/NN) (PP of/IN (NP B-lymphoid/JJ cell/NN lines/NNS))))))))) ./.)
(S-COOD (S (NP-SBJ-28 The/DT human/JJ CD19/NN gene/NN) (VP has/VBZ (VP been/VBN (VP cloned/VBN (NP *-28/-NONE-))))) ,/, and/CC (S (NP-SBJ-29 several/JJ BSAP-binding/JJ sites/NNS) (VP have/VBP (VP been/VBN (VP mapped/VBN (NP *-29/-NONE-) (PP by/IN (NP (ADJP in/FW vitro/FW) protein-DNA/JJ binding/NN studies/NNS)))))) ./.)
(S (PP In/IN (NP particular/JJ)) ,/, (NP-SBJ-COOD (NP a/DT high-affinity/JJ BSAP-binding/JJ site/NN) (CONJP instead/RB of/IN) (NP a/DT TATA/NN sequence/NN)) (VP is/VBZ (ADJP-PRD located/JJ (PP in/IN (NP (NP the/DT -30/CD promoter/NN region/NN) (ADJP upstream/JJ (PP of/IN (NP (NP a/DT cluster/NN) (PP of/IN (NP heterogeneous/JJ transcription/NN start/NN sites/NNS))))))))) ./.)
(S (ADVP Moreover/RB) ,/, (NP-SBJ-31 this/DT site/NN) (VP is/VBZ (VP occupied/VBN (NP *-31/-NONE-) (PP by/IN (NP-LGS (NP BSAP/NN) (ADVP in/FW vivo/FW))) (PP-COOD (PP in/IN (NP a/DT CD19-expressing/JJ B-cell/NN line/NN)) but/CC (PP not/RB in/IN (NP (NP-COOD (NP plasma/NN) or/CC (NP HeLa/NN)) cells/NNS))))) ./.)
(S (NP-SBJ-32 This/DT high-affinity/JJ site/NN) (VP-COOD (VP has/VBZ (VP been/VBN (VP conserved/VBN (NP *-32/-NONE-) (PP in/IN (NP (NP the/DT promoters/NNS) (PP of/IN (NP (UCP-COOD both/CC (ADJP human/JJ) and/CC (NP mouse/NN)) CD19/NN genes/NNS))))))) and/CC (VP was/VBD (ADVP furthermore/RB) (VP shown/VBN (S (NP-SBJ *-32/-NONE-) (VP to/TO (VP confer/VB (NP B-cell/NN specificity/NN) (PP to/TO (NP a/DT beta-globin/NN reporter/NN gene/NN)) (PP in/IN (NP transient/JJ transfection/NN experiments/NNS)))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ-34 BSAP/NN) (VP was/VBD (VP found/VBN (S (NP-SBJ *-34/-NONE-) (VP to/TO (VP be/VB (NP-PRD (NP the/DT only/RB abundant/JJ DNA-binding/JJ activity/NN) (PP of/IN (NP B-cell/NN nuclear/JJ extracts/NNS)) (SBAR (WHNP-35 that/WDT) (S (NP-SBJ *T*-35/-NONE-) (VP interacts/VBZ (PP with/IN (NP the/DT CD19/NN promoter/NN))))))))))) ./.)
(S (ADVP Together/RB) ,/, (NP-SBJ this/DT evidence/NN) (ADVP strongly/RB) (VP implicates/VBZ (NP BSAP/NN) (PP in/IN (NP (NP the/DT regulation/NN) (PP of/IN (NP the/DT CD19/NN gene/NN))))) ./.)
